14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 20 May 2024

Trading levels for RYTM

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 39.81 1.63 %
R2 39.62 1.15 %
R1 39.50 0.85 %
Current price: 39.17
Support S1 39.12 -0.130 %
S2 39.00 -0.431 %
S3 38.81 -0.92 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 44.06 12.48 %
R2 40.00 2.12 %
R1 39.35 0.460 %
Current price 39.17
Support S1 39.12 -0.128%
S2 38.92 -0.638%
S3 38.01 -2.96%

RYTM Predictions History

1 year ago
makaiowarren.335073 predicted that RYTM for 2022-08-04 is going

Rank:

1 year ago
JS predicted that RYTM for 2022-07-25 is going $11.97 (3.55%)

1 year ago
makaiowarren.335073 predicted that RYTM for 2022-07-25 is going

Rank:

5 years ago
NameNotImportant predicted that RYTM for 2019-05-06 is going $25.31 (-1.33%)

5 years ago
NameNotImportant predicted that RYTM for 2019-05-01 is going $25.09 (0.24%)

Click to get the best stock tips daily for free!

About Rhythm Pharmaceuticals Inc

Rhythm Pharmaceuticals Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström s... RYTM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT